Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: An EORTC GITCCG study
- 1 July 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (8) , 1310-1313
- https://doi.org/10.1016/0959-8049(96)00070-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pancreatic Cancer: Multimodality treatment of locally advanced pancreatic cancerAnnals of Oncology, 1994
- Activity of cisplatin in adenocarcinoma of the pancreasEuropean Journal Of Cancer, 1993
- Cancer of the pancreas: 50 years of surgeryCancer, 1987
- Survival in 1001 Patients with Carcinoma of the PancreasAnnals of Surgery, 1987
- Phase II study of epirubicin in advanced adenocarcinoma of the pancreasEuropean Journal of Cancer and Clinical Oncology, 1985
- Comparison of Conventional Surgical Resection, Radioactive Implantation, and Bypass Procedures for Exocrine Carcinoma of the Pancreas 1975–1980Annals of Surgery, 1984
- Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study groupCancer, 1981
- Carcinoma of the pancreasThe American Journal of Surgery, 1975
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958